The APAC antibody discovery market is observing robust development, fueled by a rising prevalence of chronic diseases and a enhanced focus on personalized treatment. Significant investment in research and innovation, particularly within countries like China, Japan, and Southern Korea, is accelerating the integration of advanced antibody identificat